In vivo research services
Preclinical services to accelerate
drug development
Let’s discuss how we can accelerate your preclinical phase!
Global partners
Segment models
Disease-specific models for rigorous preclinical testing
Explore our advanced preclinical disease models designed to evaluate therapeutic efficacy, accelerate drug development and support the translation of promising treatments.
100+
Completed projects
20+
Years of experience
10+
Global Partners
Several
international scientific publications
In vivo research services
In vivo capabilities
01
In vivo imaging
Advanced in vivo imaging for longitudinal monitoring of disease progression and treatment response.
Read more →
02
Drug validation
Preclinical drug validation to assess therapeutic potential, biological activity and treatment response.
Read more →
03
Drug efficacy
In vivo drug efficacy studies to evaluate therapeutic response, dose effects and treatment outcomes.
Read more →
04
Biodistribution studies
Biodistribution studies to track drug delivery, tissue distribution and target-specific accumulation in vivo.
Read more →
05
Toxicology assessment
Preclinical toxicology studies to evaluate drug safety, tolerability and potential adverse effects.
Read more →
06
Preclinical study design
Customized preclinical study design tailored to disease models, therapeutic targets and drug development goals.
Read more →
Why choose ivrs?
Built for better decisions in preclinical drug development
Save time
Generate high-quality longitudinal data through advanced in vivo imaging and efficient preclinical study workflows.
Reduce costs
Longitudinal in vivo studies reduce variability and animal use while generating more data from each study.
Real-time insights
Monitor disease progression and treatment response over time to support earlier, data-driven decisions.
Let us help you guide decision-making for preclinical development
Do you want to learn more about our work and how we can help you?